Daniel Wilson to Cholesterol, LDL
This is a "connection" page, showing publications Daniel Wilson has written about Cholesterol, LDL.
Connection Strength
0.278
-
Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial. Drugs Aging. 2015 Dec; 32(12):1055-65.
Score: 0.107
-
Prevalence and coexistence of cardiovascular comorbidities among the US dyslipidemic population aged = 65 years by lipid-lowering medication use status. Postgrad Med. 2010 Sep; 122(5):142-9.
Score: 0.074
-
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. Am J Kidney Dis. 2009 May; 53(5):741-50.
Score: 0.067
-
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol. 2008 Apr 15; 51(15):1448-54.
Score: 0.016
-
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1131-9.
Score: 0.015